Style | Citing Format |
---|---|
MLA | Pourfarzi F, et al.. "Socio-Economic Inequality in Prevalence of Type 2 Diabetes Among Adults in North-West of Iran: A Blinder-Oaxaca Decomposition." Journal of Diabetes and Metabolic Disorders, vol. 21, no. 2, 2022, pp. 1519-1529. |
APA | Pourfarzi F, Rezaei S, Malekzadeh R, Etemadi A, Zahirian Moghadam T, Zandian H (2022). Socio-Economic Inequality in Prevalence of Type 2 Diabetes Among Adults in North-West of Iran: A Blinder-Oaxaca Decomposition. Journal of Diabetes and Metabolic Disorders, 21(2), 1519-1529. |
Chicago | Pourfarzi F, Rezaei S, Malekzadeh R, Etemadi A, Zahirian Moghadam T, Zandian H. "Socio-Economic Inequality in Prevalence of Type 2 Diabetes Among Adults in North-West of Iran: A Blinder-Oaxaca Decomposition." Journal of Diabetes and Metabolic Disorders 21, no. 2 (2022): 1519-1529. |
Harvard | Pourfarzi F et al. (2022) 'Socio-Economic Inequality in Prevalence of Type 2 Diabetes Among Adults in North-West of Iran: A Blinder-Oaxaca Decomposition', Journal of Diabetes and Metabolic Disorders, 21(2), pp. 1519-1529. |
Vancouver | Pourfarzi F, Rezaei S, Malekzadeh R, Etemadi A, Zahirian Moghadam T, Zandian H. Socio-Economic Inequality in Prevalence of Type 2 Diabetes Among Adults in North-West of Iran: A Blinder-Oaxaca Decomposition. Journal of Diabetes and Metabolic Disorders. 2022;21(2):1519-1529. |
BibTex | @article{ author = {Pourfarzi F and Rezaei S and Malekzadeh R and Etemadi A and Zahirian Moghadam T and Zandian H}, title = {Socio-Economic Inequality in Prevalence of Type 2 Diabetes Among Adults in North-West of Iran: A Blinder-Oaxaca Decomposition}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {21}, number = {2}, pages = {1519-1529}, year = {2022} } |
RIS | TY - JOUR AU - Pourfarzi F AU - Rezaei S AU - Malekzadeh R AU - Etemadi A AU - Zahirian Moghadam T AU - Zandian H TI - Socio-Economic Inequality in Prevalence of Type 2 Diabetes Among Adults in North-West of Iran: A Blinder-Oaxaca Decomposition JO - Journal of Diabetes and Metabolic Disorders VL - 21 IS - 2 SP - 1519 EP - 1529 PY - 2022 ER - |